Investments, Funding & Disinvestment

This decision follows a recommendation from the Pandemic Fund’s Accreditation Panel and positions Africa CDC among a select group of institutions authorised to directly receive, manage, and deploy Pandemic Fund resources.

The commitment was announced during a High-Level Emergency Meeting convened by H.E. Évariste Ndayishimiye, President of Burundi and Chairperson of the African Union.

Through the collaboration, the two companies aim to help healthcare providers improve efficiency, streamline operations, and enhance the quality of care delivered to patients.

The agreement brings together Protillion’s computational biology platform with Merck’s established drug development expertise to support the discovery of next-generation therapies.

The latest upgrades follow the recent arrival of advanced multi-energy radiotherapy machines destined for Mpilo and Parirenyatwa hospitals, part of a broader government initiative to improve access to specialised cancer treatment across Zimbabwe.

The investment forms part of the company’s broader plan to spend US$55 billion on expanding its domestic manufacturing footprint through 2029.

The deal combines acquisition with a concurrent private placement of up to US$64 million in gross proceeds before expenses, strengthening development funding.

Scientia Vascular develops advanced access products designed to improve simplicity and precision during neurovascular interventions.

The partnership grants Lilly global rights to AlzeCure’s preclinical small-molecule candidate, ACD680, which targets the biology of Alzheimer’s disease.

Novanta plans to finance the acquisition using a combination of cash on hand, proceeds from a recently completed US$300 million equity raise, and its existing credit facilities.